Antibiotic tolerance
PLoS Pathog
.
2020 Oct 15;16(10):e1008892.
doi: 10.1371/journal.ppat.1008892.
eCollection 2020 Oct.
Authors
Lars F Westblade
1
2
,
Jeff Errington
3
,
Tobias Dörr
4
5
6
Affiliations
1
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America.
2
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America.
3
The Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
4
Weill Institute for Cell and Molecular Biology and Department of Microbiology, Cornell University, Ithaca, New York, United States of America.
5
Department of Microbiology, Cornell University, Ithaca, New York, United States of America.
6
Cornell Institute of Host-Pathogen Interactions and Disease, Cornell University, Ithaca, New York, United States of America.
PMID:
33057409
PMCID:
PMC7561168
DOI:
10.1371/journal.ppat.1008892
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Anti-Bacterial Agents / pharmacology*
Drug Resistance, Bacterial*
Drug Tolerance*
Evolution, Molecular*
Humans
Substances
Anti-Bacterial Agents
Grants and funding
R01 AI143704/AI/NIAID NIH HHS/United States